Current report filing

Document and Entity Information Document

v3.22.4
Document and Entity Information Document
Dec. 05, 2022
Cover [Abstract]  
Document Type 8-K/A
Document Period End Date Dec. 05, 2022
Entity Registrant Name Ekso Bionics Holdings, Inc.
Entity Central Index Key 0001549084
Amendment Flag true
Amendment Description This Amendment No. 1 on Form 8-K/A (“Amendment No. 1”) amends the Current Report on Form 8-K of Ekso Bionics Holdings, Inc. (the “Company”) filed with the Securities and Exchange Commission on December 5, 2022 (the “Initial Filing”), in which the Company reported, among other things, the closing of its acquisition from Parker Hannifin Corporation, an Ohio corporation (the “Seller”), of certain assets related to the Seller’s human motion control business, and software applications, support services and cloud environments related to such business (the “HMC Business”). This Amendment No. 1 amends the Initial Filing to provide the financial statements and pro forma financial information required by Items 9.01(a) and 9.01(b) of Form 8-K that were previously omitted from the Initial Filing in reliance on Items 9.01(a)(3) and 9.01(b)(2) of Form 8-K. This Amendment No. 1 does not amend any other item of the Initial Filing and all other information previously reported in or filed with the Initial Filing is hereby incorporated by reference to this Amendment No. 1.
Entity Incorporation, State or Country Code NV
Entity File Number 001-37854
Entity Tax Identification Number 99-0367049
Entity Address, Address Line One 101 Glacier Point, Suite A
Entity Address, City or Town San Rafael
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94901
City Area Code 510
Local Phone Number 984-1761
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol EKSO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false